CMND’s Post-Effective Amendment Cleared by SEC on 18-Jun-25

Rhea-AI Filing Summary

On June 18, 2025, the U.S. Securities and Exchange Commission declared effective Clearmind Medicine Inc.’s post-effective amendment to its registration statement (Submission Type: POS AM, File No. 333-276913, Accession No. 0001213900-25-053898). This Notice of Effectiveness (Form EFFECT) confirms that the company’s shelf registration is now operative.

The filing contains no financial statements, earnings data, or details of securities to be immediately issued. It is a routine administrative step that gives Clearmind Medicine the legal authority to offer and sell the securities covered by the registration statement at a future date; it does not, by itself, change the company’s operations or financial position.

Positive

• SEC clearance now allows Clearmind Medicine to issue securities under its registration statement, potentially improving future funding flexibility.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine SEC effectiveness; permits future security issuance, no immediate financial impact or new information disclosed.

The Notice of Effectiveness simply marks the SEC’s approval of Clearmind Medicine’s post-effective amendment. Investors should understand that this step is largely procedural. It authorizes the company to tap capital markets under previously filed terms but provides no specifics on timing, size, or pricing of any potential offering. Because no operational or financial metrics are included, the filing is best viewed as neutral until the company announces an actual capital-raising transaction.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 18, 2025

Accession Number:

0001213900-25-053898

Submission Type:

POS AM

CIK:	0001892500
Company Name:	Clearmind Medicine Inc.
File Number:	333-276913

FAQ

What did Clearmind Medicine (CMND) file with the SEC on June 18 2025?

The company filed a Notice of Effectiveness (Form EFFECT) confirming its post-effective amendment became effective.

What is the accession number for the CMND effectiveness filing?

The accession number is 0001213900-25-053898.

Does the filing include any financial results or earnings data?

No. The effectiveness notice is administrative only and contains no financial statements or earnings information.

What does an SEC Notice of Effectiveness allow Clearmind Medicine to do?

It permits the company to legally offer and sell the securities covered by the now-effective registration statement.

Is this effectiveness notice material to CMND’s current operations?

The filing is largely procedural; material impact depends on whether and when the company pursues an actual securities offering.